BUSINESS & ECONOMICS
The Hunger Shift: How GLP-1s are Rewriting Commercial Food Economics
As appetite-suppressing GLP-1 drugs rewrite consumer demand, food conglomerates and restaurants are shrinking portions to protect margins, even as self-insured employers roll back coverage over soaring costs.
Signalpoint TeamAnalysis
As appetite-suppressing GLP-1 drugs rewrite consumer demand, food conglomerates and restaurants are shrinking portions to protect margins, even as self-insured employers roll back coverage over soaring costs.
Unlock the full piece
Sign in to read the complete deep dive — signals, claims, and sources. Free account — Apple, Google, or email.
Or read free in the app